Wall Street is positive on Kura Oncology Inc (KURA). On average, analysts give KURA a Strong Buy rating. The average price target is $38.2, which means analysts expect the stock to add by 208.06% over the next twelve months. That average ranking earns KURA an Analyst Rating of 72, which is better than 72% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating KURA a Strong Buy today. Find out what this means to you and get the rest of the rankings on KURA!